There are no patient organizations that specifically represent individuals with alpha 2-antiplasmin. The following resources are involved in the study or management of this condition:
The Rare Coagulation Disorders Subcommittee of the National Hemophilia Foundation (a group appointed by the Foundation’s Medical and Scientific Advisory Council)